missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ CSGLCAT Polyclonal Antibody
GREENER_CHOICE

Rabbit Polyclonal Antibody

Brand:  Invitrogen™ PA5101521

Product Code. 16687994

  • £448.00 / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Antibody detects endogenous levels of total CSGLCAT.

CSGlcA-T belongs to the chondroitin N-acetylgalactosaminyltransferase family. It transfers glucuronic acid (GlcUA) from UDP-GlcUA to N-acetylgalactosamine residues on the non-reducing end of the elongating chondroitin polymer. CSGlcA-T has no N-acetylgalactosaminyltransferase activity.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CSGLCAT
Polyclonal
Unconjugated
CHPF2
Chondroitin glucuronyltransferase; Chondroitin polymerizing factor 2; chondroitin sulfate glucuronyltransferase; Chondroitin synthase 3; chondroitin synthase-3; CHPF2; chPF-2; CHSY3; ChSy-3; CSGlcAT; CSGlcA-T; KIAA1402; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase; UNQ299/PRO339
Rabbit
Affinity Chromatography
RUO
54480
-20°C
Liquid
Western Blot, Immunocytochemistry
1 mg/mL
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Q9P2E5
CHPF2
A synthesized peptide derived from human CHPF2(Accession Q9P2E5), corresponding to amino acid residues G36-V86.
100 μL
Primary
Human
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.